Medicare Enrolled

Dr. Leana Oppenheim, D.O

Neurology · St Petersburg, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1201 5TH AVE N STE 202, St Petersburg, FL 33705
7278207701
In practice since 2013 (12 years)
NPI: 1326487174 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Oppenheim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oppenheim? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Oppenheim

Dr. Leana Oppenheim is a neurology specialist in St Petersburg, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Oppenheim performed 430 Medicare services across 312 unique beneficiaries.

Between the years covered by Open Payments, Dr. Oppenheim received a total of $29,985 from 67 pharmaceutical and/or device companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Oppenheim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ 430 Medicare services $29,985 industry payments

Medicare Practice Summary

Medicare Utilization ↗
430
Medicare services
Bottom 45% in FL for neurology
312
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~36 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 239 $91 $310
Hospital follow-up visit, high complexity 70 $94 $257
New patient office visit (45-59 min) 45 $123 $408
Initial hospital admission, high complexity 34 $137 $498
New patient office visit, complex (60-74 min) 24 $145 $541
Office visit, established patient, complex (40-54 min) 18 $138 $435
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$29,985
Total received (2018-2024)
Avg $4,284/year across 7 years
Top 12% in FL for neurology
67
Companies
400
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22,485 (75.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,500 (25.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,988
2023
$11,944
2022
$767
2021
$518
2020
$216
2019
$1,099
2018
$452

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$22,259
Biogen, Inc.
$488
Teva Pharmaceuticals USA, Inc.
$469
Novartis Pharmaceuticals Corporation
$433
PFIZER INC.
$356
Allergan Inc.
$342
Alexion Pharmaceuticals, Inc.
$341
UCB, Inc.
$321
GE HealthCare
$304
Neurocrine Biosciences, Inc.
$297
Takeda Pharmaceuticals U.S.A., Inc.
$256
Sunovion Pharmaceuticals Inc.
$254
MITSUBISHI TANABE PHARMA AMERICA, INC.
$253
ARGENX US, INC.
$228
Lilly USA, LLC
$224
Acorda Therapeutics, Inc
$215
Allergan, Inc.
$187
Eisai Inc.
$165
Biohaven Pharmaceuticals, Inc.
$163
Medtronic, Inc.
$159
Lundbeck LLC
$133
CATALYST PHARMACEUTICALS, INC.
$124
Horizon Therapeutics plc
$120
Sumitomo Pharma America, Inc.
$106
CSL Behring
$106
Ortho Dermatologics, a division of Bausch Health US, LLC
$99
Supernus Pharmaceuticals, Inc.
$95
GE HEALTHCARE
$81
Amgen Inc.
$78
BANNER LIFE SCIENCES, LLC
$72
SK Life Science, Inc.
$65
Genentech USA, Inc.
$65
PORTOLA PHARMACEUTICALS, INC.
$62
Neurelis, Inc.
$62
Grifols USA, LLC
$58
Celgene Corporation
$51
Otsuka America Pharmaceutical, Inc.
$50
ACADIA Pharmaceuticals Inc
$49
Biohaven Pharmaceutical Holding Company Ltd.
$49
Harmony Biosciences LLC
$49
JAZZ PHARMACEUTICALS INC.
$48
Merz Pharmaceuticals, LLC
$47
Vanda Pharmaceuticals Inc.
$46
Upsher-Smith Laboratories LLC
$43
AbbVie Inc.
$41
Janssen Pharmaceuticals, Inc
$41
Sarepta Therapeutics, Inc.
$29
Nevro Corp.
$29
Alnylam Pharmaceuticals Inc.
$29
Avanir Pharmaceuticals, Inc.
$27
UPSHER-SMITH LABORATORIES LLC
$26
Jazz Pharmaceuticals Inc.
$25
NOVARTIS PHARMACEUTICALS CORPORATION
$24
TG Therapeutics, Inc.
$23
Microtransponder, Inc.
$23
IMPEL PHARMACEUTICALS INC.
$22
AbbVie, Inc.
$20
Xeris Pharmaceuticals, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Corium, LLC
$19
IDORSIA PHARMACEUTICALS US INC
$16
Zyla Life Sciences
$15
EMD Serono, Inc.
$15
Amneal Pharmaceuticals LLC
$14
Zyla Life Sciences, Inc.
$14
Medtronic USA, Inc.
$12
Egalet US Inc
$11
Top 3 companies account for 77.4% of total payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AGAMREE · AJOVY · AMYVID · ANDEXXA · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · COMIRNATY · Duopa · EMGALITY · EPIDIOLEX · Evrysdi · FIRDAPSE · Fintepla · GAMMAGARD · GILENYA · GVOKE PFS · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KISUNLA · Leqembi · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Ongentys · PLEGRIDY · PONVORY · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rystiggo · SILIQ · SOLIRIS · SPINRAZA · SPRIX · SYNCHROMED · Senza · TOPIRAMATE Extended Release Capsules · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XARELTO · XCOPRI · XYREM · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $6,973 per 100 Medicare services performed
Looking for a neurology specialist in St Petersburg?
Compare neurologists in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
161
Per 100K population
16.8
County median income
$70,293
Nearest hospital
ST ANTHONYS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Oppenheim is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 12% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Oppenheim experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Oppenheim performed 239 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oppenheim receive payments from pharmaceutical companies?
Yes. Dr. Oppenheim received a total of $29,985 from 67 companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oppenheim's costs compare to other neurologists in St Petersburg?
Dr. Oppenheim's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oppenheim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →